Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
80 Biggest Movers From Yesterday
10:32am, Wednesday, 26'th Feb 2020
Gainers
Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 77.4% to close at $5.80 on Tuesday.
Cocrystal Pharma Inc (NASDAQ: COCP) shares surged 64.7% to close at $2.19 on...
AxoGen (NASDAQ:AXGN) Stock Price Down 17% Following Weak Earnings
06:52am, Wednesday, 26'th Feb 2020
Shares of AxoGen, Inc (NASDAQ:AXGN) were down 17% on Tuesday following a dissappointing earnings announcement. The stock traded as low as $11.80 and last traded at $12.12, approximately 926,569 shares
AxoGen (AXGN) Receives a Buy from BTIG
02:32pm, Tuesday, 25'th Feb 2020
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on AxoGen (AXGN), with a price target of $19.00. The company's shares
AxoGen (AXGN) Receives a Buy from BTIG
02:32pm, Tuesday, 25'th Feb 2020
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on AxoGen (AXGN – Research Report), with
AxoGen (NASDAQ:AXGN) Announces Earnings Results, Misses Expectations By $0.01 EPS
12:44pm, Tuesday, 25'th Feb 2020
AxoGen (NASDAQ:AXGN) released its quarterly earnings data on Monday. The medical equipment provider reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09)
AxoGen's (AXGN) "Buy" Rating Reaffirmed at Canaccord Genuity
11:38am, Tuesday, 25'th Feb 2020
AxoGen (NASDAQ:AXGN)‘s stock had its “buy” rating reiterated by research analysts at Canaccord Genuity in a research report issued to clients and investors on Tuesday, AnalystRatings.com reports
Canaccord Genuity Keeps a Buy Rating on AxoGen (AXGN)
11:15am, Tuesday, 25'th Feb 2020
In a report released yesterday, Kyle Rose from Canaccord Genuity reiterated a Buy rating on AxoGen (AXGN), with a price target of $22.00. The company's
Canaccord Genuity Keeps a Buy Rating on AxoGen (AXGN)
11:15am, Tuesday, 25'th Feb 2020
In a report released yesterday,
Kyle Rose
from Canaccord Genuity reiterated a
Buy
rating on AxoGen (
AXGN
–
Research Report
), with a price target of
$22.00
. The company’s shares closed last Mond
AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q4 2019 Results - Earnings Call Transcript
03:14am, Tuesday, 25'th Feb 2020
AxoGen, Inc. (NASDAQ:AXGN) Q4 2019 Earnings Conference Call February 24, 2020 04:30 PM ET Company Participants Peter Mariani - Chief Financial Officer Karen Zad
AxoGen Inc (AXGN) Q4 2019 Earnings Call Transcript
03:00am, Tuesday, 25'th Feb 2020
AXGN earnings call for the period ending December 31, 2019.
AxoGen: 4Q Earnings Snapshot
09:25pm, Monday, 24'th Feb 2020
ALACHUA, Fla. (AP) _ AxoGen Inc. (AXGN) on Monday reported a loss of $7 million in its fourth quarter. On a per-share basis, the Alachua, Florida-based company said it had a loss of 18 cents. The re
Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results
09:01pm, Monday, 24'th Feb 2020
ALACHUA, Fla., Feb. 24, 2020 -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today.
Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results
09:01pm, Monday, 24'th Feb 2020
ALACHUA, Fla., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions...
AxoGen (NASDAQ:AXGN) Stock Rating Upgraded by BidaskClub
09:54am, Monday, 24'th Feb 2020
BidaskClub upgraded shares of AxoGen (NASDAQ:AXGN) from a sell rating to a hold rating in a report issued on Thursday, BidAskClub reports. Several other equities research analysts have also recently i
